Systematic Screening for COPD in Tabacology Consultation

Impact of Systematic Screening for COPD in Tabacology Consultation

COPD is a very common disease, an estimated 3 million people are affected in France. Unfortunately, this pathology is under-diagnosed. Several reasons can be mentioned: the banality of the symptoms or the several comorbidities.

Screening faces a major difficulty: the realization of a spirometry. Various studies have shown the complexity of the implementation of mass screening in cities by mini-spirometry.

The COPD World Health Days allow this mass screening but without visibility on the actual entry into a care pathway.

The objective of this study is to assess the impact of systematic screening for COPD during a tabacology consultation

Inclusion Criteria:

• Subjects over 45 years old, followed in Tabacology unit at CHRU of BREST - No COPD patient or COPD patients not followed for more than 3 years (considered out of care)
• No opposition filed

Exclusion Criteria:

• Patients already followed for COPD
• Contraindication to spirometry
• Refusal to participate